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ABSTRACT
Gab2 is a large disordered protein that regulates several cellular signalling 
pathways and is overexpressed in different forms of cancer. Because of its disordered 
nature, a detailed characterization of the mechanisms of recognition between Gab2 
and its physiological partners is particularly difficult. Here we provide a detailed 
kinetic characterization of the binding reaction between Gab2 and the C-terminal 
SH3 domain of the growth factor receptor-bound protein 2 (Grb2). We demonstrate 
that Gab2 folds upon binding following an induced fit type mechanism, whereby 
recognition is characterized by the formation of an intermediate, in which Gab2 is 
primarily disordered. In this scenario, folding of Gab2 into the bound conformation 
occurs only after binding. However, an alanine scanning of the proline residues of 
Gab2 suggests that the intermediate contains some degree of native-like structure, 
which might play a role for the recognition event to take place. The results, which 
represent a fundamental step forward in the understanding of this functional protein-
protein interaction, are discussed on the light of previous structural works on these 
proteins.
INTRODUCTION
The Grb2-associated binding protein 2 (Gab2) is 
74 kDa scaffolding protein that is involved in functional 
cellular signalling and cancer development [1–4]. It 
is composed of large disordered regions and various 
structural domains and docking sites that act as a platform 
for the assembly of several protein-protein interactions 
[5]. While lacking any enzymatic activity, Gab2 is a direct 
mediator of receptor tyrosine kinases and non- receptor 
tyrosine kinases, such as cytokine and G-protein–
coupled receptors, transmitting and amplifying signals 
to downstream effectors [6–8]. In fact, upon stimulation, 
Gab2 activates and binds to several targets involved in 
signal transduction and has a role in a variety of cellular 
functions, such as proliferation, survival, migration, and 
differentiation [9–11].
Gab2 is implicated in a number of cancers of both 
solid and haematological origin. In particular, Gab2 is 
overexpressed in breast [12], gastric [13] and lung [14] 
cancers. Furthermore, its role is clearly established in 
haematological cancers, like juvenile myelomonocytic 
leukaemia [15], chronic myelogenous leukemia (CML) 
[16], acute leukaemia [17] and acute lymphoblastic 
leukaemia [18]. Importantly, whilst the functions of Gab2 
are critical in the embryonic and postnatal development, 
its expression in a healthy mature cell is relatively 
suppressed. For these reasons, targeting Gab2 provides 
a promising route to develop new strategies for highly 
selective drug therapies in anticancer treatment. In fact, 
this protein acts at the head of signalling networks, 
by conveying inputs from membrane receptors to the 
cytoplasm, where it dictates the functions of multiple 
pathways.
www.impactjournals.com/oncotarget/              Oncotarget, 2017, Vol. 8, (No. 47), pp: 82344-82351
                                                               Research Paper
Oncotarget82345www.impactjournals.com/oncotarget
From a structural perspective, the N-terminal part 
of Gab2 consists of a Pleckstrin Homology domain 
(of about 120 amino acids), which binds the lipid 
phosphatidylinositol-3, 4, 5-triphosphate of the plasma 
membrane and is critical for the membrane localization 
of the protein [5], whereas the remainder of the protein 
(whose total length is 676 amino acids) essentially lacks 
any defined secondary or tertiary structure, such that Gab2 
may be classified as an intrinsically disordered protein 
(IDP).
The disordered regions of Gab2 have a fundamental 
functional relevance, by promoting the direct interaction 
with a number of cytoplasmic partners containing SH2 or 
SH3 domains [10, 19–21]. Typically, upon binding to their 
specific partners, the disordered regions of Gab2 encounter 
a disorder-to-order transition, as exemplified for example 
in [22]. Because of this complexity, being the IDPs 
typically elusive to a mechanistic characterizations [23], 
the detailed mechanisms of interactions between Gab2 and 
its physiological partners have remained elusive.
One of the critical physiological interactions 
involving Gab2 lies in the binding with Grb2 [19]. This 
recognition occurs between the C-terminal SH3 domain 
of the latter protein (Grb2 SH3C) and a region of Gab2 
encompassing residues 503-524 (Gab2503-524) [24], which 
is predominantly disordered in isolation whereas it adopts 
a polyproline type II fold upon binding (Figure 1) [24]. 
Interestingly, in its unbound state Gab2503-524 has a degree 
of propensity to adopt conformations resembling the 
Grb2-bound state [22]. Whilst the structural features of 
Gab2503-524 has been described both in its free state and 
when bound the Grb2 SH3C [24], little is known about 
the mechanism of recognition between these two elements. 
Characterising this mechanism of recognition is of great 
importance for understanding both the molecular basis 
underlying the role of Gab2 in functional and pathological 
processes and for the general structural basis of protein-
protein interactions by IDPs. In this work, we address this 
important open question by providing a detailed kinetic 
characterization on the recognition between Gab2503-524  
and Grb2 SH3C. Binding kinetics, measured both in 
the μs and ms time range, were obtained by monitoring 
intrinsic fluorescence using both a stopped flow and 
temperature jump techniques. In agreement with what 
expected from a disordered system [25, 26], data reveal 
the presence of complex kinetics, which enabled the 
identification of at least two kinetic steps. We show that 
a comparison between the experiments performed by 
varying the concentration of Gab2503-524 or Grb2 SH3C 
reveals unambiguously that the reaction occurs via an 
induced fit type mechanism, whereby the folding of 
Gab2503-524 to a polyproline type II structure is subsequent 
to the formation of an initial encounter complex, despite 
its partial character of polyproline II when in the unbound 
Figure 1: Cartoon representation of the Gab2-Grb2 SH3C complex. Three-dimensional structure of the complex between the 
C-terminal SH3 domain of the Grb2 protein (Grb2 SH3C) and a peptide representing the residues 503-524 of the Grb2-associated binding 
protein 2 (Gab2503-524). The SH3 domain is represented in gray while the peptide is represented in red. The four proline residues of Gab2503-
524 are highlighted in blue. The picture was generated using the software PyMOL (pdb code: 2vwf). Crystallization conditions were 50mM 
HEPES pH 7.5, 50mM NaCl (peptide:protein 3:1 molar ratio); reservoir: 0.7 M tri-sodium citrate, 0.1 M Tris pH 8.5.
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state. Furthermore, by performing an alanine scanning of 
the four proline residues of Gab2503-524, we observe that 
the association rate constant between the two molecules 
correlate with the stability of the polyproline type II 
structure, an observation that supports the view that the 
initial encounter complex, whilst not fully folded, contains 
some native-like secondary interactions, as also suggested 
by the NMR analysis of the isolated fragment [22].
RESULTS AND DISCUSSION
Understanding the mechanism of binding between 
two molecules requires first to establish the simplest 
kinetic scheme describing the reaction adequately and 
then to infer the mechanistic details [27]. Accordingly, 
the rational of our experimental efforts to unveil the 
recognition between Gab2503-524 and Grb2 SH3C was 
focused first on unveiling the order of events and 
subsequently on understanding the main features of the 
reaction.
A folding after binding mechanism describes the 
recognition between Gab2503-524 and Grb2 SH3C
An intrinsically disordered protein, such as 
Gab2503-524, may explore a disorder-to-order transition 
upon binding to its physiological partner. In these cases, 
from a mechanistic perspective, it may be argued that 
the reaction could occur via two extreme mechanisms, 
namely conformational selection, formally equivalent 
to a Monod−Wyman−Changeaux model, [28] or folding 
after binding, equivalent to an induced fit model [29]. 
Although conformational selection requires the IDP to 
populate at least partly the folded state in the free form, 
i.e. as observed for Gab2503-524 [22], the pre-existence of 
ordered structures in IDPs does not necessarily commit to 
a conformational selection mechanism, and kinetic studies 
are needed to address these questions [30].
In an effort to understand the order of the events in 
the folding reaction of Gab2503-524 upon binding to Grb2 
SH3C, we resorted to apply a kinetic test, originally 
introduced by Olson et al [31] and more recently applied 
on different protein systems [32–34]. This experimental 
strategy is essentially based on the comparison of the 
observed binding kinetics when performing pseudo-first 
order experiments with respect to each ligand. Thus, 
we performed relaxation binding experiments between 
Gab2503-524 and Grb2 SH3C by temperature jump. In 
particular, a constant concentration of Grb2 SH3C was 
mixed with different excess concentrations of Gab2503-524  
and the resulting solution was subjected to a rapid 
increase of temperature of 9°C, from 16 to 25°C, using 
capacitor-discharge temperature-jump instrument. 
Similarly, we performed binding experiments by keeping 
the concentration of Gab2503-524 constant and varying the 
concentration of an excess of Grb2 SH3C. Binding was 
observed by monitoring the change in fluorescence of 
Grb2 SH3C, which is primarily ascribed to residues W35 
and W36. A typical temperature jump trace is reported in 
Figure 2A. Under all the experimental conditions here 
considered, the binding time courses were consistent 
with a single exponential decay. While this observation, 
to a first approximation, may be consistent with a two-
state mechanism, a detailed analysis of the observed rate 
constants, as shown below, revealed an additional level of 
complexity.
A plot of the observed relaxation rate constants as 
a function of reactant concentration is reported in Figure 
2B. The experiments performed under pseudo-first order 
conditions of the two different reactants provide data that 
are in both cases consistent with a hyperbolic dependence. 
This finding suggests that the observed kinetics is more 
complex than a simple two-state model, where a linear 
behavior would be expected, and at least a bimolecular 
and monomolecular step may be detected. For the nature 
of the reaction, we postulate these steps to be ascribed 
to a mechanism of binding and subsequent folding of 
Gab2503-524 into a polyproline type II structure. Since both 
experiments provide very similar values of observed rate 
constants, it may be concluded that the reaction occurs via 
an induced-fit type mechanism, whereby Gab2503-524 tends 
to recognize Grb2 SH3C in a relatively unstructured state 
and folding follows binding. In fact, it has been previously 
demonstrated that, due to its symmetry with respect to 
the reactants, only the induced fit scenario can account 
for a hyperbolic behavior when performing pseudo-first 
order experiments with respect to both ligands [31, 32, 
34]. In contrast, in the case of conformational selection 
mechanism, an approximately linear dependence of the 
observed rate constant would have been observed when 
the concentration of Gab2503-524 was higher than the 
concentration of Grb2 SH3C.
In order to validate further the kinetic parameters 
obtained from pseudo-first-order experiments, we 
resorted to measure the dissociation rate constants with 
an additional method. In analogy to classical experiments 
on heme proteins [35], we carried out displacement 
experiments where a pre-incubated complex between two 
partners was challenged with an excess of a competing 
reactant. Thus, we performed displacement by producing 
a double mutant variant of Grb2 SH3C where the two 
fluorescent tryptophan residues were replaced with two 
tyrosines (W35Y/W36Y). Because W35Y/W36Y has a 
very different fluorescence yield compared to wild type 
Grb2 SH3C, a displacement between the pre-formed 
complex triggered by a rapid mix with an excess of 
W35Y/W36Y could be readily monitored. The observed 
dissociation rate constant was found insensitive to 
concentration of all the reactants and provided a value 
of koff = 350 ± 30 s
-1. As shown in Figure 2, this value 
is consistent with what extrapolated from relaxation 
experiments.
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Figure 2: Binding kinetics between Grb2 SH3C and Gab2503-524 performed by using a temperature jump apparatus at 
25°C. (A) Typical temperature jump time course obtained in a (un)binding experiment between Grb2 SH3C 4 μM and Gab2503-524 15 μM. 
Line is the best fit to a single exponential decay. (B) Plot of the observed relaxation rate constants as a function of reactant concentration. 
Pseudo-first-order binding experiments were performed by keeping the concentration of Grb2 SH3C at 4 μM and varying the concentration 
of Gab2503-524 (empty circles), and keeping the concentration of Gab2503-524 at 2 μM and varying the concentration of Grb2 SH3C (filled 
circles). In both cases the observed rate constants follow a hyperbolic behavior. The square symbol refer to the rate constant obtained from 
displacement experiments. (C) Displacement experiment. A pre-incubated complex of wild type Grb2 SH3C (10 μM) and Gab2503-524 (10 
μM) was rapidly mixed with an excess of Grb2 SH3C variant W35Y/W36Y. The line is the best fit to an exponential decay.
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Addressing the mechanism of recognition 
between Gab2503-524 and Grb2 SH3C by 
mutagenesis
It has been recently suggested that the proline 
residues of Gab2503-524 play a critical role both in tuning 
the preformed structure of the isolated protein and in 
modulating the affinity for Grb2 SH3C [22]. Thus, in an 
effort to understand directly the role of this position in the 
reaction mechanism, we carried out an alanine scanning of 
the four proline residues of Gab2503-524 and characterized 
the binding kinetics of the variants P510A, P511A, P512A 
and P519A. With the exception of P519, none of the other 
proline residues appear to participate directly to binding 
by establishing direct contacts with Grb2 SH3C. In order 
to compare the effect of mutagenesis more accurately, we 
performed these experiments by reducing the experimental 
temperature to 10°C and, therefore, measuring reaction 
kinetics using a stopped-flow apparatus. In these 
conditions, whilst we could not explore the full hyperbolic 
dependence of the observed rate constants (being too 
fast at high reactant concentrations for the stopped-flow 
apparatus), we could measure the apparent association 
and dissociation rate constant with higher precision. 
Importantly, control experiments with wild type Gab2503-524 
show that the rate constants obtained with stopped-flow 
methodology were consistent with those obtained by 
temperature jump. Whilst for the variant P511A we could 
not measure any detectable binding, the observed pseudo-
first-order rate constant for the P510A, P512A and P519A 
variant are reported in Figure 3. From the measured 
parameters a KD of 2.5 ± 0.2 μM, 2.5 ± 0.1 μM and 12 ± 
1 μM could be calculated for P510A, P512A and P519A 
respectively.
It is of interest to comment on the magnitude of 
the association rate constants of the different variants 
(Figure 3). In fact, earlier NMR analysis of the same 
variants suggested a clear ranking of WT > P510A > 
P512A > P519A > P511A in the tendency of populating 
preformed Grb2-bound like structures [22]. Accordingly, 
investigation of the data in Figure 3 suggests a similar 
trend when the association rate constant is taken into 
account. In particular, the lower the tendency of Gab2503-524 
to explore pre-formed structure, the lower its rate constant 
of association to Grb2 SH3C. This finding appears to 
contrast our observation that the recognition between the 
two molecules occurs via a pure induced fit mechanism 
and suggests that some embryonic native-like secondary 
structure might be present in the initial encounter 
complex. On the basis of these observations, we suggest 
that, whilst the overall kinetics of binding is consistent 
with an induced fit scenario, at a molecular level a mixed 
mechanism may occur. More specifically, we propose that 
some pre-formed bound-like conformations are adopted 
by the disordered Gab2503-524, which confers some features 
of conformational selection. Thus, some native-like 
structure might be present already at the early stages of 
binding with Grb2 SH3C.
CONCLUSIONS
A comprehensive understanding of the binding 
between Gab2503-524 and Grb2 SH3C, a crucial 
interaction in normal cellular signalling for a number 
of cancer conditions, demands the full description 
of their mechanism of recognition. By performing a 
combined stopped-flow and temperature jump kinetic 
Figure 3: Alanine scanning of the proline residues of Gab2503-524 measured by using a stopped-flow apparatus at 10°C. 
The observed rate constants are plotted as a function of increasing Gab2503-524 concentration, while keeping Grb2 SH3C at a constant 
concentration of 0.5 μM. In each graph both Gab2503-524 wild-type (filled circles) and mutant (empty circles) are shown. Mutant P511A was 
not shown because it was not possible to measure any detectable binding. The observed rate constants follow a linear dependence from 
which the association (kon) and dissociation (koff) rate constants can be calculated. The calculated kon and koff for Gab2503-524 wild-type are 43 
± 1 μM-1 s-1 and 53 ± 7 s-1 respectively.
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study, we successfully demonstrated that these two 
molecules bind through a initial encounter complex, 
whose characterization is potentially very important 
to the identification of molecules able to hijack this 
interaction and therefore to inhibit the aberrant functions 
of Gab2 in a number of solid and haematological 
cancers. Whilst the mechanism is formally similar to 
an induced fit scenario, the analysis of variants tuning 
the residual structure in Gab2503-524 indicates that the 
initial complex contains some embryonic bound-like 
secondary structure that funnels the binding energy 
landscape thereby effectively accelerating the formation 
of the macromolecular complex. Future work based on 
extensive site directed mutagenesis will shed light on 
the detailed structural features of such a metastable 
complex.
MATERIALS AND METHODS
Protein expression and purification
The sequence encoding for the Grb2 SH3C 
domain, subcloned in a pET28-b+ plasmid was used 
to transform E.coli cells (BL21). Expression of the 
protein was obtained growing bacterial cells in LB 
medium, at 37°C until they reached OD600 = 0.6-0.8 and 
then induced with IPTG at the concentration of 1mM 
at 37°C over night. Cells were then collected through 
centrifugation.
To purify the protein, pellet was resuspended in 
buffer TrisHCl 50mM, NaCl 0.5M, pH 7.5, with the 
addition of antiprotease tablet (Roche), then bacterial 
cells were lysed by sonication and centrifuged. The lysate 
was loaded onto a Nickel-charged Hi-trap Chelating 
column (GE Healthcare) equilibrated with buffer TrisHCl 
50mM, NaCl 0.5M, 10mM Imidazole, pH 7.5 and eluted 
with a gradient from 10mM to 1M Imidazole using an 
ÄKTA-prime system. Fractions containing the purified 
protein were analysed through SDS-page and collected. 
Buffer was then exchanged with 25mM HEPES, 100mM 
potassium acetate, pH 7.5.
The Gab2503-524 peptide in its wild-type form 
(SRGSEIQPPPVNRNLKPDRKAK) and its variants were 
purchased from JPT, Germany. Peptide concentrations 
were measured by weighting 1 mg of the sample in an 
analytical balance and concentration was further confirmed 
by measuring absorbance at 205 nm.
Temperature-jump binding experiments
Kinetic experiments were performed using a PTJ-
64 capacitor-discharge T-jump apparatus (TgK Scientific). 
Temperature was rapidly changed with a jump-size of 
9°C, from 16°C to 25°C. The buffer used was 25mM 
HEPES, 100mM potassium acetate, pH 7.5, the excitation 
wavelength was 296 nm, and the fluorescence emission 
was collected using a 320-nm cut-off glass filter. 
Binding experiments were performed by keeping Grb2 
SH3C concentration constant at 4 μM and varying the 
concentration of Gab2503-524 from 2.5 μM to 45 μM, and 
keeping Gab2503-524 concentration constant at 2 μM and 
varying the concentration of Grb2 SH3C from 2 μM to 20 
μM. All the observed relaxation rate constants obtained 
and analysed were calculated from the average of 10 
individual traces.
Stopped-flow binding experiments
Binding kinetics experiments were carried out 
on a single-mixing SX-18 stopped-flow instrument 
(Applied Photophysics); the excitation wavelength used 
was 280 nm and the fluorescence emission was collected 
using a 320-nm cut-off glass filter. Pseudo-first order 
binding experiments were performed mixing a constant 
concentration of Grb2 SH3C (0.5μM) versus increasing 
concentration of Gab2503-524, from 1μM to 10μM, in its 
wild-type form and its variants P510A, P511A, P512A, 
and from 1μM to 12μM for the P519A variant.
For all binding experiments the temperature was 
10°C and the buffer used was 25mM HEPES, 100mM 
potassium acetate, pH 7.5. The observed rate constants 
were calculated from the average of 3-6 single traces. 
Association rate constants (kon) were calculated as the 
slope of a linear function fitting the observed rate constants 
versus ligand concentration, while dissociation rate 
constants (koff) were calculated either from extrapolation 
as the intercept of y-axis, or from separate displacement 
experiments.
Stopped-flow displacement experiments
The dissociation rate constant was measured by 
carrying out displacement experiments on a single-mixing 
SX-18 stopped-flow instrument (Applied Photophysics); 
the excitation wavelength used was 280 nm and the 
fluorescence emission was collected using a 320-nm 
cut-off glass filter. A pre-incubated complex of wild type 
Grb2 SH3C (10 μM) and Gab2503-524 (10 μM) was rapidly 
mixed with an excess of Grb2 SH3C variant W35Y/W36Y 
(100 μM and 200 μM). Displacement experiments were 
performed at 25°C, in presence of 25mM HEPES, 100mM 
potassium acetate, pH 7.5. The observed rate constants 
were calculated from the average of 5 single traces. 
Observed kinetics was consistent with a single exponential 
decay.
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